BET inhibition synergizes with RLR signaling to enhance tumor immunogenicity and T cell recognition
{{output}}
Intratumoral signaling via the cytosolic double-stranded RNA (dsRNA) receptors RIG-I and MDA-5 enhance antitumor immunity and can overcome resistance to cancer immunotherapy. Although BET proteins are established epigenetic drivers of immune escape mechanisms,... ...
